INFU logo

INFU
InfuSystem Holdings Inc

614
Mkt Cap
$205.05M
Volume
196,430.00
52W High
$11.04
52W Low
$5.08
PE Ratio
26.98
INFU Fundamentals
Price
$9.94
Prev Close
$10.16
Open
$10.04
50D MA
$9.65
Beta
1.13
Avg. Volume
94,382.41
EPS (Annual)
$0.3141
P/B
3.49
Rev/Employee
$303,247.36
$210.50
Loading...
Loading...
News
all
press releases
What Makes InfuSystems Holdings (INFU) a New Buy Stock
InfuSystems Holdings (INFU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·4h ago
News Placeholder
More News
News Placeholder
Looking for a Growth Stock? 3 Reasons Why InfuSystems Holdings (INFU) is a Solid Choice
InfuSystems Holdings (INFU) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·2d ago
News Placeholder
Is InfuSystems Holdings (INFU) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·10d ago
News Placeholder
InfuSystems Holdings, Inc. (INFU) Q1 Earnings Top Estimates
InfuSystems Holdings (INFU) delivered earnings and revenue surprises of +25.00% and -2.37%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates
InfuSystems Holdings (INFU) delivered earnings and revenue surprises of +53.85% and -0.74%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of +13.52% and +1.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of -1.30% and +0.48%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Wall Street Analysts Predict a 40% Upside in InfuSystems Holdings (INFU): Here's What You Should Know
The consensus price target hints at a 40% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·7mo ago
News Placeholder
Should Value Investors Buy InfuSystems Holdings (INFU) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·7mo ago
News Placeholder
InfuSystems Holdings, Inc. (INFU) Tops Q3 Earnings Estimates
InfuSystems Holdings (INFU) delivered earnings and revenue surprises of +37.50% and -1.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7mo ago
<
1
2
...
>

Latest INFU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.